 |
인쇄하기
취소
|
Jassen anticancer drug ‘Dacogen Inj.’ expands insurance coverage to Leukemia
(Korean Doctors Weekly)
Myelodysplasticsyndrome treatment of Jassen Korea, Dacogen( ingredient : decitabine).is available to acute myelocyte leukemia which could not apply semi inducing therapy age over 65 from December 1.
But, the applied patients should be 20% or more of Bone marrow blasts based on WHO classification.
This insurance coverage enlargement of Dacogen was done due to cov...
Myelodysplasticsyndrome treatment of Jassen Korea, Dacogen( ingredient : decitabine).is available to acute myelocyte leukemia which could not apply semi inducing therapy age over 65 from December 1.
But, the applied patients should be 20% or more of Bone marrow blasts based on WHO classification.
This insurance coverage enlargement of Dacogen was done due to cov...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.